Stock Market
Pfizer Stock: Long-Term Potential and Investment Strategy
By Bullbit Editorial ยท March 30, 2026
- WhatPfizer lags behind Eli Lilly and Novo Nordisk in the GLP-1 race.
- WhyInvestors shouldn't count Pfizer out for long-term gains.
- SignalPfizer's GLP-1 pipeline shows promise despite current setbacks.
- TargetPfizer's stock price could increase significantly in the next few years.
- RiskInvestors should be aware of the potential risks and challenges in the pharmaceutical industry.
More breaking news โ